CareDx Inc
(NAS:CDNA)
$
46.69
+1.88 (+4.2%)
Market Cap: 2.42 Bil
Enterprise Value: 2.06 Bil
PE Ratio: 22.56
PB Ratio: 5.65
GF Score: 67/100 CareDx Inc at Goldman Sachs Healthcare Conference Transcript
Jun 08, 2026 / 05:20PM GMT
Release Date Price:
$21.95
(-1.35%)
Evie Koslosky
Goldman Sachs - Analyst
Good afternoon, everyone. I'm Evie Koslosky, Head of the Life Science Tools and Diagnostics team here at Goldman Sachs. I'm joined here today with CareDX. So thank you for coming.
John Hanna
CareDx Inc - President, Chief Executive Officer, Director
Thanks so much for having us, Evie. We really appreciate it. I'm John Hanna. I'm the CEO here at CareDX, and I'm joined by Keith Kennedy, our COO and CFO.
Questions & Answers
Evie Koslosky
Goldman Sachs - Analyst
Great. So I guess just to kind of kick things off, your strategy since joining the company as CEO, John, has been to transform CareDx into a precision oncology leader. I guess, can you talk through the strategy and what this means at a high level and key initiatives that you have in place to kind of achieve this precision medicine goal?
John Hanna
CareDx Inc - President, Chief Executive Officer, Director
Yeah, thanks so much. We really view CareDx as a precision
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot